Related Experiment Video
Updated: Nov 30, 2025

05:47
Isolation of Murine Lymph Node Stromal Cells
Published on: August 19, 2014
31.9K
Tissue-Engineered Stromal Reticula to Study Lymph Node Fibroblastic Reticular Cells in Type I Diabetes
Freddy Gonzalez Badillo1,2, Flavia Zisi Tegou1,2, Riccardo Masina2
1Department of Biomedical Engineering, University of Miami, 1251 Memorial Dr, Coral Gables, FL 33146 USA.
Cellular and Molecular Bioengineering
|November 13, 2020
Summary
Fibroblastic reticular cells (FRCs) in Type 1 diabetes (T1D) models show altered network structures. Engineered FRC networks in 3D scaffolds better mimic T1D lymph nodes and enhance autoreactive T cell engagement.
Area of Science:
- Immunology
- Cell Biology
- Diabetes Research
Background:
- Fibroblastic reticular cells (FRCs) are crucial for lymph node (LN) structure and immune tolerance.
- In Type 1 diabetes (T1D), altered FRCs may impair the presentation of self-antigens to T cells, hindering tolerance.
- FRC network organization is vital for adaptive immunity.
Purpose of the Study:
- To engineer lymph node-like FRC reticula to investigate FRC alterations in T1D.
- To study the engagement of autoreactive T cells with FRCs in a 3D environment.
Main Methods:
- Characterized FRC networks in pancreatic and skin-draining LNs of non-obese diabetic (NOD) and resistant (NOR) mice.
- Cultured murine and human FRCs in collagen sponges to create 3D reticula.
- Co-cultured FRCs expressing T1D antigens with specific T cells in 2D and 3D scaffolds to assess T cell engagement.
Main Results:
- NOD mice exhibited larger reticular pores in LN FRC networks compared to NOR controls.
- NOD FRCs showed delayed remodeling in 3D scaffolds and reduced gp38 marker expression, which improved in 3D.
- FRC reticula expressing T1D antigens facilitated greater autoreactive T cell engagement than 2D cultures.
Conclusions:
- Developed engineered LN-like FRC reticula that mimic the organization and phenotype of FRCs in T1D LNs.
- These 3D models provide a platform for studying T1D-related tolerogenic autoreactive T cell engagement.

